Spots Global Cancer Trial Database for renal failure
Every month we try and update this database with for renal failure cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use | NCT02922543 | Multiple Myelom... | 18 Years - | Celgene | ||
| Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) | NCT03098589 | Lymphoma | Revlimid | 18 Years - | Celgene | |
| Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor | NCT01314391 | Kidney Cancer Renal Failure | mutation analys... polymerase chai... laboratory biom... | - 15 Years | Children's Oncology Group | |
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | NCT01366144 | Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment | NCT03234335 | Multiple Myelom... Renal Failure | Data collection | 66 Years - | Centre Hospitalier Universitaire de Saint Etienne | |
| Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure | NCT00416897 | Multiple Myelom... Renal Failure | chemotherapy dexamethasone plasmapheresis | 18 Years - | National Cancer Institute (NCI) | |
| SELF-BREATHE RCT for Chronic Breathlessness | NCT04574050 | Cancer COPD Asthma Bronchiectasis ... Interstitial Lu... Cystic Fibrosis Chronic Heart F... Sickle Cell Dis... Renal Failure Liver Failure Post COVID-19 Dyspnea | SELF-BREATHE | 18 Years - | King's College Hospital NHS Trust | |
| Optimising Renal Outcome in Myeloma Renal Failure | NCT02424851 | Multiple Myelom... Chronic Kidney ... | Bortezomib Thalidomide Bendamustine Dexamethasone | 18 Years - | Oxford University Hospitals NHS Trust | |
| Comparing N-terminal-proB-type Natriuretic Peptide With Other Criteria in Pleural Fluid Analysis | NCT05797649 | Pleural Effusio... Heart Failure Malignant Neopl... Fluid Overload Hypoalbuminemia Renal Failure Cirrhosis Infections | 18 Years - | Chinese University of Hong Kong | ||
| Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer | NCT04823923 | Kidney Neoplasm | blood sampling ... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Fernald Community Cohort -18 Year Observational Study | NCT02295085 | Cancer Renal Failure Diabetes Cardiovascular ... | 8 Years - | University of Cincinnati | ||
| Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism | NCT00123461 | Secondary Hyper... Renal Failure Chronic Renal I... | Hectorol (doxer... | 18 Years - | Sanofi | |
| Comparing N-terminal-proB-type Natriuretic Peptide With Other Criteria in Pleural Fluid Analysis | NCT05797649 | Pleural Effusio... Heart Failure Malignant Neopl... Fluid Overload Hypoalbuminemia Renal Failure Cirrhosis Infections | 18 Years - | Chinese University of Hong Kong | ||
| Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure | NCT01084837 | Multiple Myelom... | velcade | 18 Years - | PETHEMA Foundation | |
| Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure | NCT04352205 | Plasma Cell Mye... Renal Failure | Bortezomib Daratumumab Dexamethasone Lenalidomide Thalidomide | 18 Years - | Emory University | |
| Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD) | NCT00854139 | Multiple Myelom... End Stage Renal... | Cyclophosphamid... Kidney transpla... Thymic irradiat... Bone marrow tra... | 18 Years - 65 Years | Massachusetts General Hospital | |
| Evaluation of Suspected Liver Pathology in Patients With Contraindications for Contrast Enhanced CT and/or MRI | NCT02651090 | Liver Metastasi... Liver Mass | Sonazoid | 18 Years - 100 Years | Northeastern Ohio Radiology Research and Education Fund | |
| Multidisciplinary Inpatient Palliative Care Intervention | NCT00325611 | Cerebrovascular... Cancer Coronary Arteri... Heart Failure, ... Diabetes Mellit... Acquired Immuno... Failure to Thri... Pulmonary Disea... Dementia Kidney Failure,... Pneumonia Liver Failure Renal Failure Respiratory Fai... Stroke | Multidisciplina... | 18 Years - | Kaiser Permanente | |
| A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use | NCT02922543 | Multiple Myelom... | 18 Years - | Celgene | ||
| Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | NCT01366144 | Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc... | Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer | NCT04823923 | Kidney Neoplasm | blood sampling ... | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients | NCT01270932 | Renal Failure Multiple Myelom... | Lenalidomide an... | 18 Years - | University Health Network, Toronto | |
| Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) | NCT03098589 | Lymphoma | Revlimid | 18 Years - | Celgene | |
| High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal Impairment | NCT03234335 | Multiple Myelom... Renal Failure | Data collection | 66 Years - | Centre Hospitalier Universitaire de Saint Etienne |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
